Table 1 Distribution of variables for cardiovascular outcomes of interest
Variables | Cardiovascular outcomes of interest | p-value | ||
|---|---|---|---|---|
Total N = 1169 | CVD N = 148 | No CVD N = 1013 | ||
Female sex, n (%) | 609 (53.3%) | 57 (38.5%) | 550 (55.7%) | < 0.001 |
Age (years), mean (± SD) | 40.0 (± 16.7) | 58.5 (± 13.7) | 37.3 (± 15.4) | < 0.001 |
Age (years), median (IQR) | 37.0 (24.9-52.0) | 59.0 (49.0-68.2) | 33.8 (23.9-47.2) | < 0.001 |
Diabetes duration (years), mean (SD) | 19.2 (± 14.4) | 34.8 (± 15.5) | 17.1 (± 12.8) | < 0.001 |
Diabetes duration (years), median (IQR) | 16.0 (8.0-27.0) | 35.0 (24.5-45.0) | 15.0 (8.0-24.0) | < 0.001 |
Diabetes duration (≥ 20.0 years), n (%) | 476 (41.3%) | 121 (84.0%) | 354 (35.4%) | < 0.001 |
HbA1c (%), mean (± SD) | 8.5 (± 1.8) | 8.6 (± 1.5) | 8.5 (± 1.9) | 0.386 |
HDL-Ca, mean (± SD) | 1.53 (± 0.54) | 1.35 (± 0.42) | 1.56 (± 0.56) | < 0.001 |
LDL-Ca, mean (± SD) | 2.55 (± 0.95) | 2.15 (± 0.82) | 2.62 (± 0.95) | < 0.001 |
Total-Ca, mean (± SD) | 4.73 (± 1.09) | 4.18 (± 1.12) | 4.83 (± 1.06) | < 0.001 |
Triglyceridesa, mean (± SD) | 1.37 (± 1.42) | 1.54 (± 1.84) | 1.34 (± 1.34) | 0.190 |
Systolic BPb, mean (± SD) | 124 (± 17) | 132 (± 21) | 123 (± 16) | < 0.001 |
Diastolic BPb, mean (± SD) | 74 (± 10) | 72 (± 10) | 74 (± 10) | 0.073 |
BMI categories, n (%) (kg/m2) | 0.372 | |||
 < 18.5 | 20 (2.0%) | 4 (3.2%) | 15 (1.7%) |  |
 18.5 to < 25 | 419 (41.6%) | 51 (40.5%) | 365 (41.8%) |  |
 25 to < 30 | 315 (31.3%) | 34 (27.0%) | 279 (31.9%) |  |
 ≥ 30 | 253 (25.1%) | 37 (29.4%) | 215 (24.6%) |  |
Ever smoked, n (%) | 397 (38.5%) | 86 (64.2%) | 309 (34.6%) | < 0.001 |
Albuminuria, n (%) | 220 (31.1%) | 46 (47.9%) | 174 (28.6%) | < 0.001 |
eGFRc, mean (± SD) | 97 (± 28) | 71 (± 29) | 101 (± 25) | < 0.001 |
Antihypertensive Rx, n (%) | 320 (28.1%) | 105 (72.9%) | 214 (21.7%) | < 0.001 |
Lipid lowering Rx, n (%) | 342 (29.7%) | 110 (75.3%) | 232 (23.2%) | < 0.001 |
Retinopathy, n (%) | 284 (24.7%) | 82 (56.2%) | 202 (20.2%) | < 0.001 |